Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infection.

Autor: Tamir H; Israel Institute for Biological Research, Ness Ziona, Israel., Noy-Porat T; Israel Institute for Biological Research, Ness Ziona, Israel., Melamed S; Israel Institute for Biological Research, Ness Ziona, Israel., Cherry-Mimran L; Israel Institute for Biological Research, Ness Ziona, Israel., Barlev-Gross M; Israel Institute for Biological Research, Ness Ziona, Israel., Alcalay R; Israel Institute for Biological Research, Ness Ziona, Israel., Yahalom-Ronen Y; Israel Institute for Biological Research, Ness Ziona, Israel., Achdout H; Israel Institute for Biological Research, Ness Ziona, Israel., Politi B; Israel Institute for Biological Research, Ness Ziona, Israel., Erez N; Israel Institute for Biological Research, Ness Ziona, Israel., Weiss S; Israel Institute for Biological Research, Ness Ziona, Israel., Rosenfeld R; Israel Institute for Biological Research, Ness Ziona, Israel., Epstein E; Israel Institute for Biological Research, Ness Ziona, Israel., Mazor O; Israel Institute for Biological Research, Ness Ziona, Israel., Makdasi E; Israel Institute for Biological Research, Ness Ziona, Israel., Paran N; Israel Institute for Biological Research, Ness Ziona, Israel., Israely T; Israel Institute for Biological Research, Ness Ziona, Israel. tomeri@iibr.gov.il.

Publikováno v: Nature communications [Nat Commun] 2024 Apr 16; Vol. 15 (1), pp. 3265. Date of Electronic Publication: 2024 Apr 16.

Insights from the Infection Cycle of VSV-ΔG-Spike Virus.

Autor: Milrot E; Department of Infectious Diseases, Israel Institute of Biological Research (IIBR), Ness-Ziona 74100, Israel., Lazar S; Department of Pharmacology, Israel Institute of Biological Research (IIBR), Ness-Ziona 74100, Israel., Schuster O; Department of Infectious Diseases, Israel Institute of Biological Research (IIBR), Ness-Ziona 74100, Israel., Makdasi E; Department of Infectious Diseases, Israel Institute of Biological Research (IIBR), Ness-Ziona 74100, Israel., Shmaya S; Department of Infectious Diseases, Israel Institute of Biological Research (IIBR), Ness-Ziona 74100, Israel., Yahalom-Ronen Y; Department of Infectious Diseases, Israel Institute of Biological Research (IIBR), Ness-Ziona 74100, Israel., Tamir H; Department of Infectious Diseases, Israel Institute of Biological Research (IIBR), Ness-Ziona 74100, Israel., Laskar O; Department of Infectious Diseases, Israel Institute of Biological Research (IIBR), Ness-Ziona 74100, Israel.

Publikováno v: Viruses [Viruses] 2022 Dec 19; Vol. 14 (12). Date of Electronic Publication: 2022 Dec 19.

Centaur antibodies: Engineered chimeric equine-human recombinant antibodies.

Autor: Rosenfeld R; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel., Alcalay R; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel., Zvi A; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel., Ben-David A; Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona, Israel., Noy-Porat T; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel., Chitlaru T; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel., Epstein E; Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona, Israel., Israeli O; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel., Lazar S; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel., Caspi N; Veterinary Center for Preclinical Research, Israel Institute for Biological Research, Ness Ziona, Israel., Barnea A; Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona, Israel., Dor E; Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona, Israel., Chomsky I; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel., Pitel S; Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona, Israel., Makdasi E; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel., Zichel R; Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona, Israel., Mazor O; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 Aug 19; Vol. 13, pp. 942317. Date of Electronic Publication: 2022 Aug 19 (Print Publication: 2022).

Development of an immunofluorescence assay for detection of SARS-CoV-2.

Autor: Atiya-Nasagi Y; The Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Milrot E; The Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Makdasi E; The Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Schuster O; The Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Shmaya S; The Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Simon I; The Department of Biotechnology, Israel Institute for Biological Research, Ness-Ziona, Israel., Ben-Shmuel A; The Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Beth-Din A; The Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona, Israel., Weiss S; The Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Laskar O; The Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel. orlyl@iibr.gov.il.

Publikováno v: Archives of virology [Arch Virol] 2022 Apr; Vol. 167 (4), pp. 1041-1049. Date of Electronic Publication: 2022 Feb 22.

Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses.

Autor: Levy Y; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 7410001, Israel., Alcalay R; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 7410001, Israel., Zvi A; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 7410001, Israel., Makdasi E; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 7410001, Israel., Peretz E; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 7410001, Israel., Noy-Porat T; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 7410001, Israel., Chitlaru T; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 7410001, Israel., Mandelboim M; The Central Virology Laboratory, Israel Ministry of Health, Tel Hashomer, Ramat Gan 5266202, Israel.; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel., Mazor O; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 7410001, Israel., Rosenfeld R; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 7410001, Israel.

Publikováno v: Vaccines [Vaccines (Basel)] 2022 Feb 07; Vol. 10 (2). Date of Electronic Publication: 2022 Feb 07.